Kendall

Kendall v. Odonate Therapeutics, Inc.

Good Law
United States District Court, Southern District of CaliforniaJune 6, 20223:20-cv-01828California5,775 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 13 KEVIN KENDALL, individually and on Case No.: 3:20-cv-01828-H-LL behalf of all others similarly situated,

ORDER:

Plaintiff, 16 v. (1) CERTIFYING SETTLEMENT

CLASS;

ODONATE THERAPEUTICS, INC.,

KEVIN C. TANG, MICHAEL HEARNE,

(2) GRANTING PLAINTIFF’S JOHN G. LEMKEY,

MOTION FOR FINAL

Defendants. APPROVAL OF CLASS ACTION SETTLEMENT; and

(3) GRANTING PLAINTIFF’S

MOTION FOR ATTORNEYS’

FEES, COSTS, AND INCENTIVE

AWARD

25 [Doc. Nos. 51, 52.] 26 On April 13, 2021, Plaintiff Kevin Kendall (“Plaintiff”) filed a second amended class action complaint against Defendants Odonate Therapeutics, Inc. (“Odonate”) and three of its officers, Kevin C. Tang, Michael Hearne, and John G. Lemkey (collectively “Defendants”) alleging violations of Section 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5. (Doc. No. 24, SAC ¶¶ 225–41.) On…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.